Natural Alternatives International, Inc.
NGM: NAIILive Quote
📈 ZcoreAI Score
Our AI model analyzes Natural Alternatives International, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get NAII Z-Score →About Natural Alternatives International, Inc.
Consumer Defensive
Packaged Foods
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
📊 Fundamental Analysis
Natural Alternatives International, Inc. demonstrates a profit margin of -9.1%, which is below the sector average, suggesting competitive pressure.
The company recently reported 2.1% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is -16.8%, which indicates that capital utilization is currently under pressure.
At a current price of $2.83, NAII currently trades near the bottom of its 52-week range (19%), indicating potential value or weakness (Range: $2.33 - $4.96).
🏥 Financial Health
🔴
Profit Margin
Weak
⚠️
Debt/Equity
Moderate
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$17.50M
Trailing P/E
--
Forward P/E
--
Beta (5Y)
0.39
52W High
$4.96
52W Low
$2.33
Avg Volume
23K
Day High
Day Low